WHO ICTRP trial

Maternal Group B Streptococcus identification study

ISRCTN37848792 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN37848792
Public title Maternal Group B Streptococcus identification study
Scientific title Molecular detection of Group B Streptococcus (GBS, Streptococcus agalactiae) in pregnant women: a study of a novel diagnostic test
Primary sponsor Cambridge University Hospitals NHS Foundation Trust
Secondary sponsors University of Cambridge
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Observational
Phase Not Applicable
Countries United Kingdom;England
Conditions Group B Streptococcus agalactiae in pregnant women Pregnancy and Childbirth
Interventions Women will be recruited from clinical areas which often require speculum examinations and swabs taken as part of the routine assessment in the Rosie Hospital, Cambridge (e.g. the Maternity Assessment Unit and the Preterm Birth Prevention…
Registration date Feb 11, 2022
Target size 200
Secondary IDs Nil known;Nil known;IRAS 307873; Funder (Addenbrooke's Charitable Trust) reference number 900336
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations